The treatment of RLS
A strategy from:
Management of restless legs syndrome in primary care
Developed by RLS:UK
Non-pharmacological intervention
Good sleep hygiene and habits are helpful; advise patients to:
- sleep in a quiet, comfortable and cool environment
- Go to bed and wake at a regular hour (advise going to bed late and waking late)
- Avoid taking diuretics or caffeine before bedtime
During an attack, patients may find benefit from:
- Walking and stretching
- Bathing in hot or cold water
- Relaxation exercises (biofeedback or yoga)
- Distracting the mind
- Massaging affected limbs
Pharmacological treatment
The drugs used in RLS generally belong to the following classes:
A: Dopaminergic agents (Levodopa, dopamine agonists, amantadine; these drugs are also used in Parkinson's disease)
B: Anti-epilepsy drugs
C: Opoids
D: Benzodiazepines
E: Iron
F: Miscellaneous
A step-by-step approach to drug therapy may be useful:
- if intolerant to one agent, try an alternative dopamine agonist
- this approach is a good long-term option
- alleviates symptoms in at least 70% of patients
- any augmentation is mild
Levodopa, taken at bedtime, may be used if patients are intolerant to dopamine agonists
- 80-82% of patients treated will experience augmentation or rebound; therefore long-term use is limited
- useful for intermittent RLS
- use with caution in patients with angle-closure glaucoma, a history of malignant melanoma, cardiac disease or peptic ulcer disease
- Rotigotine transdermal patch may be particularly useful as it is administered once daily
- these drugs work by inhibiting hyperactivity in the nervous system that may be related to the symptoms
- Gabapentin is particularly useful for haemodialysis parients and for cases of painful RLS
Treatment strategies summarised
Dopaminergic drugs:
- Licensed for the treatment of moderate to severe RLS
- Good for periodic limb movements
- Low rates of augmentation
- Licensed for the treatment of moderate to severe RLS
- Good for periodic limb movements
- Low rates of augmentation
Dose range - 0.25-4 mg od
Rotigotine (transdermal patch)
- Licensed for moderate to advanced RLS
Dose range - 1-3 mg/24hrs
Cabergoline
- Related to cardiac valvulopathy
- Needs monitoring with echocardiography
- No longer recommended as first-line treatment
Dose range - 0.5-2 mg (single evening dose)
Pergolide
- Related to cardiac valvulopathy
- Needs monitoring with echocardiography
- No longer recommended as first-line treatment
Dose range - 0.1-0.75 mg od/bid
Bromocriptine
- Poor tolerance (preferably avoided)
- No longer recommended as first-line treatment
Dose range - 7.5 mg (divided dose)
Apomorphine
- Specialist monitoring required. Only recommended for severe RLS in Parkinson's disease
Dose range - 18-50 mg / 12hrs, overnight sc infusion
Levodopa DCI
- Rebound/augmentation
- Useful for intermittent RLS
Dose range - 100-600 mg evening or divided dose
Other drugs:
Gabapentin
- Quick dose escalation
- Useful second-line agent
- Painful RLS
- Useful in dialysis related RLS
Dose range - 300-2400 mg
Carbamazepine
- Single/divided doses
Dose range - 100-600 mg
Oxycodone
- Painful RLS
Dose range - 2.5-25 mg
Tramadol
- Painful RLS and insomnia
Clonazepam
- Useful for associated insomnia
Dose range - 0.5-2 mg evening dose
Triazolam
- As above
Dose range - 0.125-0.25 mg
Nitrazepam
- As above
Dose range - 2.5-10 mg
Clonodine
- Uraemia
Dose range - 0.15-2 0.9mg
Iron sulphate
- Iron deficiency (low ferritin levels)

